Cargando…
MRPL12 Acts as A Novel Prognostic Biomarker Involved in Immune Cell Infiltration and Tumor Progression of Lung Adenocarcinoma
Mitochondrial ribosomal protein L7/L12 (MRPL12) is a member of the mitochondrial ribosomal proteins (MRPs). However, the biological function of MRPL12 in lung adenocarcinoma (LUAD) remains unclear. The expression and prognostic value of MRPL12 in LUAD were systematically analyzed using UALCAN, TIMER...
Autores principales: | Hu, Yangyang, Liu, Yue, Ma, Chenchao, Ai, Kaixing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917664/ https://www.ncbi.nlm.nih.gov/pubmed/36769082 http://dx.doi.org/10.3390/ijms24032762 |
Ejemplares similares
-
MRPL13 is a Prognostic Cancer Biomarker and Correlates with Immune Infiltrates in Breast Cancer
por: Tao, Zuo, et al.
Publicado: (2020) -
MRPL42 is activated by YY1 to promote lung adenocarcinoma progression
por: Jiang, Wei, et al.
Publicado: (2021) -
LRMP Associates With Immune Infiltrates and Acts as a Prognostic Biomarker in Lung Adenocarcinoma
por: Jin, Xin, et al.
Publicado: (2021) -
CXCL2 acts as a prognostic biomarker and associated with immune infiltrates in stomach adenocarcinoma
por: Zhang, Jingxin, et al.
Publicado: (2022) -
MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer
por: Xu, Haoya, et al.
Publicado: (2021)